enquiry@goldsteinresearch.com
We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. | × |
---|
Understand the COVID-19 Outbreak and its impact on global & regional businesses
request free proposal
Insights on a world turned upside down : Re-imagining
The post-COVID19 Business resilience & recovery
How effective strategies and business recovery plans are winning the race
request free proposal
Goldstein Market Intelligence help you navigate through the COVID-19 crisis,
we will provide you most relevant market insights on crisis management,
recovery strategy & business continuity.
2020-09-01
762
Global
A biopsy is a test conducted by surgeon, cardiologist or radiologist which involves withdrawal of certain cell or tissues to examine the existence of some disease in the body. It is observed under microscope by surgeon or pathologist. The extracted cell or tissues are examined to know that the particular cell is cancerous or not, and if they are then what type of cancer is present.
Geographically, North America is the largest region holding around 33.5% market share in 2016. Western Europe is the second largest region accounting for over 26.2% market share in 2016 following North America. This is due to increase adoption of hybrid imaging technology in the entire region.
One of the major factors that propel the growth of liquid biopsy market is through a single extraction of cell from the body, patient disease can be easily known. However, expensive treatment of such procedures can hamper the global liquid biopsy market from growth.
On the basis of product:
On the basis of cancer type:
On the basis of technology:
On the basis of end user:
On the basis of region:
Global liquid biopsy market is an emerging market globally and will show an exponential growth in six to seven years. Global Liquid Biopsy Market was valued at USD 635.25 million in 2016, and is estimated to registering a CAGR of 28.9% from 2017 to 2030.
On the basis of technology the circulating tumor cells segment is accounted for the largest share of the global liquid biopsy market in 2016, followed by the circulating tumor DNA segment.
Geographically, North America is the largest region in global liquid biopsy market which is accounted for 33% market share in 2016.
Europe is the second region followed by North America in global liquid biopsy market. Europe is the second largest region crossing the value of USD 685.02 million by 2024 followed by APAC
A number of constituents such as soaring circumstances of cancer, increasing awareness about biopsy to population and rising government initiatives to create awareness propel the growth of liquid biopsy market and tends the market towards growth.
However, unclear regulatory reimbursement scenario, expensive medical procedure and cost intensive research process may hamper the global liquid biopsy market from growing.
Impact of COVID-19 Outbreak on “Global Liquid Biopsy Market ”, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Global Liquid Biopsy Market . It also showcases the expected recovery schedule and losses in the industry and other various major factors.
Opportunities and risk factors:
There are several opportunities which can tend the growth of markets such as surge in prevalence of cancer and rise in awareness about minimally invasive methods among the patient pool
Several risk factors involve in these market are there are several multiple test going on, several experiments takes place that sometimes fails and also there is no surety that the experiment will succeed or not.
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
OR Call Us:+1-646-568-7747Global Point of Care Testing (POCT) Devices Market Outlook: Market Segmentation By Systems Basis, By Clinical Specialties & Diseases, By Areas of Use, By End User & by Region With COVID-19 impact & Forecast 2017-2030
Global Home Healthcare Equipment Market Size , Share, By Device, By Distribution Channel, By End User With COVID-19 impact & Forecast 2017-2030
Global Connected Healthcare Market Analysis by type, by function(Home/Remote Monitoring, Clinical Monitoring) & by application with regional outlook and forecast to 2030
India In-Vitro Diagnostics (IVD) Market Outlook 2030: Based on Healthcare Segments, Based on Application, Based on End User With COVID-19 impact & Forecast 2017-2030
Global Connected Medical Device Market Outlook 2030: Based on Product Type, By Devices, Based on Application, By End-User, Based on Geography With COVID-19 impact & Forecast 2017-2030